Journal
BLOOD
Volume 102, Issue 4, Pages 1290-1297Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2002-11-3490
Keywords
-
Categories
Funding
- NCI NIH HHS [1R01-CA91839] Funding Source: Medline
- NIAID NIH HHS [1R01-AI43433] Funding Source: Medline
- NIDDK NIH HHS [R01 DK059380] Funding Source: Medline
Ask authors/readers for more resources
Interleukin-3 (IL-3) and stem cell factor (SCF) are important mast cell growth and differentiation factors. Since both cytokines; activate the transcription factor signal transducer and activator of transcription 5 (Stat5), a known regulator of proliferation and survival, we investigated the effects of Stat5 deficiency on mast cell development and survival. Bone marrow-derived mast cell (BMMC) popu-lations cultured from Stat5A/B-deficient mice survived in IL-3 + SCF, but not in either cytokine alone. These cells demonstrated reduced expression of Bcl-2, Bcl-x(L), cyclin A2, and cyclin B1, with increased apoptosis and delayed cell cycle progression during IL-3 or SCIF culture. Finally, the absence of Stat5 resulted in loss of in vivo mast cell development, as judged by assessments of Stat5-deficient mice and transplantation. of Stat5-deficient bone marrow cells to mast cell-deficient recipient mice. These results indicate that Stat5A and Stat5B are critical regulators of in vitro and in vivo mast cell development and survival. (C) 2003 by The American Society of Hematology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available